कुल 50 हाल के अंदरूनी लेनदेन दर्ज हैं Astrana Health, Inc. (ASTH), जिसमें शामिल हैं 10 खरीद और 39 बिक्री. कुल अंदरूनी खरीद मूल्य RSU पुरस्कार और कुल अंदरूनी बिक्री मूल्य $21.53M.
हाल की गतिविधि वाले उल्लेखनीय अंदरूनी लोगों में शामिल हैं Basho Chandan, Kumar Dinesh M., Sobotka Glenn. अंदरूनी लेनदेन से पता चल सकता है कि कंपनी का नेतृत्व स्टॉक के मूल्यांकन और भविष्य की संभावनाओं को कैसे देखता है.
इनसाइडर ट्रेडिंग — ASTH
| तिथि |
नाम |
भूमिका |
लेनदेन प्रकार |
शेयर |
औसत मूल्य |
मूल्य |
स्वामित्व वाले शेयर |
| 2026-04-02 |
Basho Chandan |
COO and CFO |
RSU कर रोक |
2,092 |
$25.05 |
$52.4K |
171,635 |
| 2026-04-01 |
Kumar Dinesh M. |
Chief Medical Officer |
RSU कर रोक |
57,980 |
$24.51 |
$1.42M |
177,655 |
| 2026-03-26 |
Sobotka Glenn |
Chief Accounting Officer |
RSU कर रोक |
662 |
$24.27 |
$16.07K |
14,039 |
| 2026-03-05 |
Lam Thomas S. |
Director |
RSU कर रोक |
9,266 |
$25.07 |
$232.3K |
423,990 |
| 2026-03-05 |
Kumar Dinesh M. |
Chief Medical Officer |
RSU कर रोक |
1,697 |
$25.07 |
$42.54K |
200,335 |
| 2026-03-05 |
Basho Chandan |
COO and CFO |
RSU कर रोक |
1,240 |
$25.07 |
$31.09K |
173,727 |
| 2026-02-02 |
Sim Brandon |
CEO and President |
विकल्प प्रयोग (बिक्री) |
21,334 |
$23.24 |
$495.8K |
- |
| 2026-01-23 |
Kumar Dinesh M. |
Chief Medical Officer |
RSU कर रोक |
10,759 |
$27.16 |
$292.21K |
202,032 |
| 2026-01-13 |
Schmidt David |
Director |
विकल्प प्रयोग (बिक्री) |
20,000 |
$5.79 |
$115.8K |
- |
| 2026-01-01 |
Kumar Dinesh M. |
Chief Medical Officer |
RSU कर रोक |
5,102 |
$24.81 |
$126.58K |
212,791 |
| 2025-12-08 |
Lam Thomas S. |
Director |
विकल्प प्रयोग (बिक्री) |
29,502 |
$17.78 |
$524.55K |
- |
| 2025-11-10 |
Mazdyasni Matthew |
Director |
विकल्प प्रयोग (बिक्री) |
20,000 |
$18.20 |
$364K |
- |
| 2025-11-10 |
Sim Kenneth T. |
Executive Chairman |
विकल्प प्रयोग (बिक्री) |
29,502 |
$17.78 |
$524.55K |
- |
| 2025-11-07 |
Kitayama Mitchell W |
Director |
विकल्प प्रयोग (बिक्री) |
12,000 |
$18.20 |
$218.4K |
- |
| 2025-11-03 |
Marsh Linda |
Director |
विकल्प प्रयोग (बिक्री) |
20,000 |
$18.20 |
$364K |
- |
| 2025-10-02 |
Basho Chandan |
COO and CFO |
RSU कर रोक |
1,979 |
$27.77 |
$54.96K |
174,967 |
| 2025-09-15 |
Kitayama Mitchell W |
Director |
विकल्प प्रयोग (बिक्री) |
8,000 |
$18.20 |
$145.6K |
12,000 |
| 2025-09-05 |
Kumar Dinesh M. |
Chief Medical Officer |
RSU कर रोक |
1,694 |
$29.70 |
$50.31K |
217,893 |
| 2025-09-05 |
Basho Chandan |
COO and CFO |
RSU कर रोक |
1,694 |
$29.70 |
$50.31K |
176,946 |
| 2025-09-02 |
Schmidt David |
Director |
विकल्प प्रयोग (बिक्री) |
20,000 |
$18.20 |
$364K |
- |
| 2025-08-13 |
Chiang John |
Director |
विकल्प प्रयोग (बिक्री) |
20,000 |
$18.20 |
$364K |
- |
| 2025-07-01 |
Kumar Dinesh M. |
Chief Medical Officer |
RSU कर रोक |
6,831 |
$25.06 |
$171.18K |
218,811 |
| 2025-06-11 |
Dai, Weili |
Director |
RSU पुरस्कार |
6,449 |
- |
- |
13,663 |
| 2025-06-11 |
Kitayama Mitchell W |
Director |
RSU पुरस्कार |
6,449 |
- |
- |
21,060 |
| 2025-06-11 |
Schmidt David |
Director |
RSU पुरस्कार |
6,449 |
- |
- |
15,763 |
| 2025-06-11 |
Marsh Linda |
Director |
RSU पुरस्कार |
6,449 |
- |
- |
83,641 |
| 2025-06-11 |
Chiang John |
Director |
RSU पुरस्कार |
6,449 |
- |
- |
23,132 |
| 2025-06-11 |
Mazdyasni Matthew |
Director |
RSU पुरस्कार |
6,449 |
- |
- |
14,763 |
| 2025-06-04 |
Kumar Dinesh M. |
Chief Medical Officer |
RSU कर रोक |
1,656 |
$25.06 |
$41.5K |
225,642 |
| 2025-05-16 |
Basho Chandan |
COO and CFO |
RSU कर रोक |
10,035 |
$27.18 |
$272.75K |
178,640 |
| 2025-04-29 |
Kumar Dinesh M. |
Chief Medical Officer |
RSU कर रोक |
828 |
$31.15 |
$25.79K |
227,298 |
| 2025-04-14 |
Basho Chandan |
COO and CFO |
RSU कर रोक |
2,683 |
$34.05 |
$91.36K |
188,675 |
| 2025-04-02 |
Basho Chandan |
COO and CFO |
RSU कर रोक |
1,394 |
$30.02 |
$41.85K |
191,358 |
| 2025-03-26 |
Sobotka Glenn |
Officer |
अज्ञात |
- |
- |
- |
- |
| 2025-03-26 |
Sobotka Glenn |
Chief Accounting Officer |
RSU पुरस्कार |
6,432 |
- |
- |
6,432 |
| 2025-03-05 |
Lam Thomas S. |
Director |
RSU कर रोक |
9,235 |
$27.19 |
$251.1K |
429,620 |
| 2025-03-05 |
Sim Brandon |
CEO and President |
RSU कर रोक |
105,795 |
$27.19 |
$2.88M |
1,023,219 |
| 2025-03-05 |
Kumar Dinesh M. |
Chief Medical Officer |
RSU कर रोक |
7,866 |
$27.19 |
$213.88K |
228,126 |
| 2025-03-05 |
Basho Chandan |
COO and CFO |
RSU पुरस्कार |
26,701 |
- |
- |
192,752 |
| 2025-02-15 |
Lam Thomas S. |
Director |
अन्य (खरीद) |
26,232 |
- |
- |
1,133,706 |
| 2025-02-15 |
Sim Kenneth T. |
Executive Chairman |
अन्य (खरीद) |
26,232 |
- |
- |
546,349 |
| 2025-02-15 |
Allied Physicians Of California, A Professional Medical Corp |
10 Percent Owner |
अन्य (बिक्री) |
699,896 |
- |
- |
6,132,802 |
| 2025-01-23 |
Kumar Dinesh M. |
Chief Medical Officer |
RSU कर रोक |
7,210 |
$37.96 |
$273.69K |
209,291 |
| 2025-01-17 |
Allied Physicians Of California, A Professional Medical Corp |
10 Percent Owner |
शेयर वापसी |
300,000 |
$35.17 |
$10.55M |
6,832,698 |
| 2025-01-01 |
Kumar Dinesh M. |
Chief Medical Officer |
RSU कर रोक |
967 |
$31.53 |
$30.49K |
215,872 |
| 2024-12-10 |
Kitayama Mitchell W |
Director |
शेयर वापसी |
5,100 |
$43.09 |
$219.76K |
14,611 |
| 2024-11-30 |
Vong John |
Chief Accounting Officer |
RSU कर रोक |
134 |
$43.25 |
$5.8K |
17,520 |
| 2024-11-22 |
Kitayama Mitchell W |
Director |
विकल्प प्रयोग (बिक्री) |
3,409 |
$18.41 |
$62.76K |
- |
| 2024-11-19 |
Chiang John |
Director |
विकल्प प्रयोग (बिक्री) |
1,515 |
$18.41 |
$27.89K |
- |
| 2024-11-18 |
Sim Kenneth T. |
Executive Chairman |
विकल्प प्रयोग (बिक्री) |
28,046 |
$18.65 |
$523.06K |
- |
■ जानकारीपूर्ण — खुले बाजार में खरीद/बिक्री (सर्वाधिक महत्वपूर्ण)
■ गैर-जानकारी खरीद — पुरस्कार, विकल्प अभ्यास, रूपांतरण
■ गैर-जानकारी बिक्री — कर रोक, पुरस्कार बिक्री
■ तटस्थ — उपहार, ट्रस्ट, समाप्ति
